ADPT logo

Adaptive Biotechnologies (ADPT) CAPEX

annual CAPEX:

$3.66M-$7.03M(-65.75%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ADPT annual capital expenditures is $3.66 million, with the most recent change of -$7.03 million (-65.75%) on December 31, 2024.
  • During the last 3 years, ADPT annual CAPEX has fallen by -$58.08 million (-94.07%).
  • ADPT annual CAPEX is now -94.07% below its all-time high of $61.75 million, reached on December 31, 2021.

Performance

ADPT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTcash flow metrics

quarterly CAPEX:

$1.26M+$1.18M(+1473.75%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT quarterly capital expenditures is $1.26 million, with the most recent change of +$1.18 million (+1473.75%) on March 31, 2025.
  • Over the past year, ADPT quarterly CAPEX has dropped by -$252.00 thousand (-16.68%).
  • ADPT quarterly CAPEX is now -94.29% below its all-time high of $22.04 million, reached on June 30, 2021.

Performance

ADPT quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTcash flow metrics

TTM CAPEX:

$3.41M-$252.00K(-6.88%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT TTM capital expenditures is $3.41 million, with the most recent change of -$252.00 thousand (-6.88%) on March 31, 2025.
  • Over the past year, ADPT TTM CAPEX has dropped by -$5.87 million (-63.25%).
  • ADPT TTM CAPEX is now -94.49% below its all-time high of $61.87 million, reached on September 30, 2021.

Performance

ADPT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTcash flow metrics

ADPT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-65.8%-16.7%-63.3%
3 y3 years-94.1%-59.1%-93.0%
5 y5 years-67.3%-57.5%-67.0%

ADPT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-94.1%at low-76.8%+1473.8%-93.0%at low
5 y5-year-94.1%at low-94.3%+1473.8%-94.5%at low
alltimeall time-94.1%+46.2%-94.3%+1473.8%-94.5%+474.4%

ADPT CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.26M(+1473.8%)
$3.41M(-6.9%)
Dec 2024
$3.66M(-65.7%)
$80.00K(-76.7%)
$3.66M(-24.9%)
Sep 2024
-
$344.00K(-80.1%)
$4.88M(-33.3%)
Jun 2024
-
$1.73M(+14.4%)
$7.32M(-21.2%)
Mar 2024
-
$1.51M(+16.4%)
$9.28M(-13.2%)
Dec 2023
$10.70M(-34.6%)
$1.30M(-53.3%)
$10.70M(-10.4%)
Sep 2023
-
$2.78M(-24.9%)
$11.94M(-18.2%)
Jun 2023
-
$3.70M(+26.4%)
$14.60M(-9.9%)
Mar 2023
-
$2.92M(+15.0%)
$16.20M(-0.9%)
Dec 2022
$16.35M(-73.5%)
$2.54M(-53.2%)
$16.35M(-29.1%)
Sep 2022
-
$5.43M(+2.5%)
$23.05M(-28.5%)
Jun 2022
-
$5.30M(+72.2%)
$32.24M(-34.2%)
Mar 2022
-
$3.08M(-66.7%)
$48.98M(-20.7%)
Dec 2021
$61.75M
$9.24M(-36.8%)
$61.75M(-0.2%)
Sep 2021
-
$14.62M(-33.7%)
$61.87M(+20.2%)
DateAnnualQuarterlyTTM
Jun 2021
-
$22.04M(+39.1%)
$51.46M(+62.4%)
Mar 2021
-
$15.84M(+69.1%)
$31.68M(+68.5%)
Dec 2020
$18.80M(+67.9%)
$9.37M(+122.7%)
$18.80M(+58.7%)
Sep 2020
-
$4.21M(+85.9%)
$11.85M(+7.0%)
Jun 2020
-
$2.26M(-23.6%)
$11.07M(+7.2%)
Mar 2020
-
$2.96M(+22.6%)
$10.33M(-7.8%)
Dec 2019
$11.20M(+77.8%)
$2.42M(-29.6%)
$11.20M(-0.7%)
Sep 2019
-
$3.43M(+125.2%)
$11.28M(+12.4%)
Jun 2019
-
$1.52M(-60.2%)
$10.04M(+5.3%)
Mar 2019
-
$3.83M(+53.5%)
$9.54M(+51.4%)
Dec 2018
$6.30M(+151.4%)
$2.50M(+13.9%)
$6.30M(+65.6%)
Sep 2018
-
$2.19M(+114.7%)
$3.80M(+135.7%)
Jun 2018
-
$1.02M(+71.7%)
$1.61M(+171.7%)
Mar 2018
-
$594.00K
$594.00K
Dec 2017
$2.51M
-
-

FAQ

  • What is Adaptive Biotechnologies annual capital expenditures?
  • What is the all time high annual CAPEX for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies annual CAPEX year-on-year change?
  • What is Adaptive Biotechnologies quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies quarterly CAPEX year-on-year change?
  • What is Adaptive Biotechnologies TTM capital expenditures?
  • What is the all time high TTM CAPEX for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies TTM CAPEX year-on-year change?

What is Adaptive Biotechnologies annual capital expenditures?

The current annual CAPEX of ADPT is $3.66M

What is the all time high annual CAPEX for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high annual capital expenditures is $61.75M

What is Adaptive Biotechnologies annual CAPEX year-on-year change?

Over the past year, ADPT annual capital expenditures has changed by -$7.03M (-65.75%)

What is Adaptive Biotechnologies quarterly capital expenditures?

The current quarterly CAPEX of ADPT is $1.26M

What is the all time high quarterly CAPEX for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high quarterly capital expenditures is $22.04M

What is Adaptive Biotechnologies quarterly CAPEX year-on-year change?

Over the past year, ADPT quarterly capital expenditures has changed by -$252.00K (-16.68%)

What is Adaptive Biotechnologies TTM capital expenditures?

The current TTM CAPEX of ADPT is $3.41M

What is the all time high TTM CAPEX for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high TTM capital expenditures is $61.87M

What is Adaptive Biotechnologies TTM CAPEX year-on-year change?

Over the past year, ADPT TTM capital expenditures has changed by -$5.87M (-63.25%)
On this page